Trust Company of Vermont’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$123K Sell
1,554
-241
-13% -$18.5K 0.01% 419
2025
Q3
$131K Sell
1,795
-11
-0.6% -$806 0.01% 402
2025
Q2
$137K Sell
1,806
-671
-27% -$47.5K 0.01% 387
2025
Q1
$188K Sell
2,477
-13,244
-84% -$986K 0.01% 351
2024
Q4
$1.04M Sell
15,721
-72
-0.5% -$5.04K 0.05% 182
2024
Q3
$1.1M Sell
15,793
-363
-2% -$21.8K 0.06% 173
2024
Q2
$854K Buy
+16,156
New +$981K 0.05% 188

Other funds holding SOLV

Trust Company of Vermont's SOLV Position: Q4 2025 in Review

Trust Company of Vermont reduced its Solventum (SOLV) stake by 13% in Q4 2025, selling an estimated $18.5K and leaving 1,554 shares worth $123K. The position accounts for 0.01% of the portfolio, ranked #419.

Trust Company of Vermont first reported a position in SOLV in Q2 2024 and has held it in 7 quarters since. The position peaked at $1.1M in Q3 2024. 938 funds tracked by Wall St. Rank hold SOLV as of Q4 2025.

  • Trust Company of Vermont held 1,554 shares of Solventum worth $123K as of Q4 2025.
  • Trust Company of Vermont sold 241 Solventum shares in Q4 2025, an estimated $18.5K.
  • Solventum made up 0.01% of Trust Company of Vermont's portfolio in Q4 2025, its #419 holding.
  • Trust Company of Vermont first reported a position in Solventum in Q2 2024 and has held it in 7 quarters since.
  • Trust Company of Vermont's Solventum position peaked at $1.1M in Q3 2024.
  • 938 funds tracked by Wall St. Rank held Solventum as of Q4 2025.

Based on Trust Company of Vermont's 13F filing for Q4 2025, filed 16 Jan 2026.